Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo

Institute of Pathobiochemistry and Molecular Neurodegeneration, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research (Impact Factor: 6.83). 02/2013; 28(2). DOI: 10.1002/jbmr.1757
Source: PubMed


The primary role of apolipoprotein E (apoE) is to mediate the cellular uptake of lipoproteins. However, a new role for apoE as a regulator of bone metabolism in mice has recently been established. In contrast to mice, the human APOE gene is characterized by three common isoforms APOE ε2, ε3 and ε4 that result in different metabolic properties of the apoE isoforms, but it remains controversial whether the APOE polymorphism influences bone traits in humans. To clarify this, we investigated bone phenotypes of apoE knock-in mice, which express one human isoform each (apoE2 k.i., apoE3 k.i., apoE4 k.i.) in place of the mouse apoE. Analysis of 12 week-old female knock-in mice revealed increased levels of biochemical bone formation and resorption markers in apoE2 k.i. animals as compared to apoE3 k.i. and apoE4 k.i., with a reduced OPG/RANKL ratio in apoE2 k.i., indicating increased turnover with prevailing resorption in apoE2 k.i.. Accordingly, histomorphometric and µCT analyses demonstrated significantly lower trabecular bone mass in apoE2 than in apoE3 and apoE4 k.i. animals, which was reflected by a significant reduction of lumbar vertebrae maximum force resistance. Unlike trabecular bone, femoral cortical thickness, and stability was not differentially affected by the apoE isoforms. To extend these observations to the human situation, plasma from middle-aged healthy men homozygous for ε2/ε2, ε3/ε3, and ε4/ε4 (n = 21, n = 80, n = 55 respectively) was analyzed with regard to bone turnover markers. In analogy to apoE2 k.i. mice, a lower OPG/RANKL ratio was observed in the serum of ε2/ε2 carriers as compared to ε3/ε3 and ε4/ε4 individuals (p = 0.02 for ε2/ε2 vs ε4/ε4). In conclusion, the current data strongly underline the general importance of apoE as a regulator of bone metabolism and identifies the APOE ε2 allele as a potential genetic risk factor for low trabecular bone mass and vertebral fractures in humans. © 2012 American Society for Bone and Mineral Research.

Download full-text


Available from: Robert Percy Marshall,
  • Source

    Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 02/2013; 28(2):234-5. DOI:10.1002/jbmr.1840 · 6.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Indolent systemic mastocytosis (ISM) can trigger bone loss. However, the clinical relevance of different mast cell infiltration patterns for bone remains to be clarified. Here, we report increased bone turnover in individuals with ISM, and its extent is rather related to the type of mast cell distribution within the bone marrow than to the presence or absence of cutaneous manifestations. INTRODUCTION: It is well established that ISM can trigger osteopenia or osteoporosis. However, neither the clinical relevance of the infiltration pattern of mast cells within the bone marrow nor the impact of the presence or absence of cutaneous mast cell infiltration has been elucidated. METHODS: We retrospectively analysed 300 cases with histologically proven ISM of the bone marrow and performed quantitative histomorphometry for a subgroup of 159 patients that did not receive any treatment before the biopsies were taken. Most importantly, since 66 % of the patients displayed ISM without the characteristic skin lesions, we were able to compare ISM with or without cutaneous manifestation. RESULTS: We found that both forms of ISM were not only characterized by a decreased trabecular bone mass but also by an increased number of osteoclasts and osteoblasts. Interestingly, when we analysed these data in relation to mast cell distribution, we found that the bone cell numbers in cases with mast cell granulomas were significantly increased compared to cases with diffuse mast cell distribution. Moreover, evidence of increased bone turnover was also found in 16 patients displaying osteosclerosis. CONCLUSION: Based on the largest cohort of bone biopsies from patients with ISM analysed so far, we could demonstrate high bone turnover, more specifically increased osteoblast and osteoclast numbers and surface indices, as a cause of the skeletal changes. Moreover, the severity of the bone disease is presumably rather dependent on the amount of mast cells and their distribution within the bone marrow irrespective of the presence or absence of cutaneous involvement.
    Osteoporosis International 02/2013; 24(8). DOI:10.1007/s00198-013-2305-x · 4.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adequate bony support is the key to reestablish both function and esthetics in the craniofacial region. Autologous bone grafting has been the gold standard for regeneration of problematic large bone defects. However, poor graft availability and donor site complications have led to alternative bone tissue engineering approaches combining osteo-inductive biomaterials and three-dimensional (3D) cell aggregates in scaffolds or constructs. The goal of the present study was to generate novel cell aggregate-loaded macro-porous scaffolds combining the osteo-inductive properties of titanium dioxide (TiO2) with hydroxyapatite-gelatin nanocomposites (HAP-GEL) for regeneration of craniofacial defects. Herein, we investigated the in vivo applicability of macro-porous (TiO2)-enriched HAP-GEL scaffolds with undifferentiated and osteogenically differentiated multipotent adult progenitor cell (MAPC and OD-MAPC, respectively) aggregates for calvaria bone regeneration. The silane coated HAP-GEL with and without TiO2 additives were polymerized and molded to produce macro-porous scaffolds. Aggregates of rat MAPC were pre-cultured, loaded into each scaffold and implanted to rat calvaria critical-size defects (CSD) to study bone regeneration. Bone autografts were used as positive controls and a poly(lactic-co-glycolic acid) (PLGA) scaffold for comparison purposes. Pre-implanted scaffolds and calvaria bone from pig were tested for ultimate compressive strength with an Instron 4411® and for porosity with microcomputerized tomography (µCT). Osteointegration and newly formed bone (NFB) were assessed by µCT and non-decalcified histology, and quantified by calcium fluorescence labeling. Results showed that macro-porous TiO2-HAP-GEL scaffold had a comparable strength relative to natural calvaria bone (13.8±4.5MPa and 24.5±8.3MPa, respectively). Porosity was 1.52±0.8mm and 0.64±0.4mm for TiO2-HAP-GEL and calvaria bone, respectively. At eight and twelve weeks post-implantation into rat calvaria defects, greater osteointegration and NFB was significantly present in the TiO2-enriched HAP-GEL constructs with OD-MAPCs, compared to the undifferentiated MAPC-loaded constructs, cell-free HAP-GEL with and without titanium, and PLGA scaffolds. Tissue-engineered TiO2-enriched HAP-GEL constructs with OD-MAPC aggregates present a potential useful therapeutic approach for calvaria bone regeneration.
    Tissue Engineering Part A 03/2013; 19(15-16). DOI:10.1089/ten.TEA.2012.0520 · 4.64 Impact Factor
Show more